Associated Papers
Assessment of CYP2D6 gene expression in liver tissue: Variability in CYP2D6 mRNA levels within genotype-predicted metabolizer phenotype groups.
Meaddough EL et al.
Chemico-biological Interactions, 2025
Trends in the Contribution of Genetic Susceptibility Loci to Hyperuricemia and Gout and Associated Novel Mechanisms.
Zhao J et al.
Frontiers in Cell and Developmental Biology, 2022
A Review of the Important Role of CYP2D6 in Pharmacogenomics.
Taylor C et al.
Genes, 2020
Transcriptional Regulation of CYP2D6 Expression.
Pan X et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2017
Krüppel-like factor 9 promotes hepatic cytochrome P450 2D6 expression during pregnancy in CYP2D6-humanized mice.
Koh KH et al.
Molecular Pharmacology, 2014
Pregnane X receptor and hepatocyte nuclear factor 4α polymorphisms are cooperatively associated with carbamazepine autoinduction.
Saruwatari J et al.
Pharmacogenetics and Genomics, 2014
Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.
Zanger UM et al.
Pharmacology & Therapeutics, 2013
Effect of HNF4α genetic polymorphism G60D on the pharmacokinetics of CYP2D6 substrate tolterodine in healthy Korean individuals.
Jiang F et al.
Pharmacogenetics and Genomics, 2013
Genetic polymorphism of hepatocyte nuclear factor-4alpha influences human cytochrome P450 2D6 activity.
Lee SS et al.
Hepatology (baltimore, Md.), 2008
Select a paper to view details